Orthofix International | OFIX - Assets


Orthofix International reported $850.65M in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Accuray USD 456.82M 13.42M Sep/2025
AngioDynamics USD 269.68M 4.04M Sep/2025
Artivion USD 884.8M 27.13M Dec/2025
AtriCure USD 654.18M 18.74M Dec/2025
Dexcom USD 6.34B 1.16B Dec/2025
EDAP TMS EUR 61.46M 6.88M Sep/2025
Globus Medical USD 5.3B 207.12M Dec/2025
Inogen USD 307.01M 5.03M Sep/2025
Insulet USD 3.19B 161.1M Dec/2025
Integra LifeSciences USD 3.6B 44.45M Dec/2025
J&J USD 199.21B 6.39B Dec/2025
Medtronic USD 91.48B 139M Dec/2025
Mesa Laboratories USD 434.85M 4.5M Dec/2025
Orthofix International USD 850.65M 18.04M Dec/2025
Plus Therapeutics USD 16.32M 2.34M Dec/2025
Smith & Nephew USD 10.69B 150M Dec/2025
STAAR Surgical USD 451.68M 4.68M Dec/2025
Stryker USD 47.84B 787M Dec/2025
Surmodics USD 169.82M 8.74M Jun/2025
Tandem Diabetes Care USD 881.11M 6.46M Dec/2025
Teleflex USD 6.95B 924.7M Dec/2025
Veracyte USD 1.41B 38.23M Dec/2025
Zimmer Biomet Holdings USD 23.09B 396.3M Dec/2025